If you have metabolic liver disease (MASLD) or its more severe form, MASH, you may be eligible to join a research study testing a new oral drug as a treatment option. This study is evaluating an investigational drug called denifanstat, which may help reduce liver fat and prevent further liver damage. By joining, you'll receive close monitoring of your liver health at no cost, and you could help advance treatment options for others with liver disease. Participation is voluntary, and you'll be able to continue your regular medical care throughout the study. If you're interested in new treatment possibilities and improving your liver health, this could be the right opportunity for you. Speak with our study team today to learn more and see if you qualify!

Are you a Black Adult interested in lowering your blood pressure? Interested in changing the way you eat? Do you sit too much at work? If you are interested in changing your lifestyle, want to lose some weight, and have a family member that wants to participate with you, you may be able to participate in a research study. Compensation provided.

We know it is hard to find an exercise program that is designed just for you. We have created a new version of an exercise program called the Physical Activity and Community EmPOWERment (PACE) program, an exercise program that helps people be more active. We are looking for people with intellectual disabilities and their caregivers to participate in a research study testing an exercise program.

We want to learn how personality traits relate to how adolescents and young adults who are shy or whose emotions and moods change quickly make decisions. We hope this research will help us better understand decision-making and mental health during the transition from adolescence to adulthood.

Do you identify as Malaysian? Are you a part of a religious organization in Malaysia? Are you interested in the state of gender equality in Malaysia? If so, you will be able to participate in a study on the challenges men in Malaysia face when involved in gender equality work. We will also explore people's opinions on their involvement. Compensation provided.

Have you been diagnosed with early-stage breast cancer or ductal carcinoma in situ (DCIS) and have undergone breast conserving surgery (lumpectomy). If so this may be the research for you!! You may be able to take part in a research study to evaluate the effects of the tumor bed boost when given at the same time (called a simultaneous integrated boost, SIB) with the WBI, as opposed to after the WBI.

Do you have incurable, metastatic, or recurrent head and neck squamous cell carcinoma? If so, you may be able to participate in a study to evaluate the addition of the anti-cancer drug, Cetuximab, to standard of care treatment.

The purpose of this study to see if the drug ruxolitinib with the drugs tacrolimus and methotrexate given before and following a peripheral blood stem cell transplant will prevent graft-versus-host disease (GVHD), a serious complication of a stem cell transplant, better than the drugs post-transplant cyclophosphamide, tacrolimus, and mycophenolate mofetil.

Do you have sickle cell trait or wonder if you might? Join our study to learn more about how having sickle cell trait could impact your health. The study uses simple lab tests, and participants receive compensation.

The purpose of this research is to evaluate the various mood symptoms linked to Perimenopausal Depression (PMD) among a diverse group of women in the menopause transition.